Rituximab to Treat Neuropathy With Anti-MAG Antibodies
Clinical trial NCT00050245 · COMPLETED
Trial details
- NCT number
- NCT00050245
- Sponsor
- National Institute of Neurological Disorders and Stroke (NINDS)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2002-11-27
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.